- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06899971
The Association Between Tau & GFAP and Postoperative Neurological Impairment in Patients Undergoing Cardiac Surgery
March 16, 2026 updated by: Koichi Yuki, Boston Children's Hospital
Patients born with heart defects often undergo surgical procedures on a heart lung machine.
With improvements in medical and surgical management, their survival has significantly improved, but their brain insult has not been paid much attention.
This study is to determine the relationship between specific proteins in the blood and brain injury in patients less than 18-year-old undergoing heart surgery.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Koichi Yuki, MD
- Phone Number: 617-355-6115
- Email: koichi.yuki@childrens.harvard.edu
Study Contact Backup
- Name: Rachel Bernier, MPH
- Phone Number: 857-218-5438
- Email: rachel.bernier@childrens.harvard.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Boston Children's Hospital
-
Contact:
- Koichi Yuki, MD
- Phone Number: 617-355-6115
- Email: koichi.yuki@childrens.harvard.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients less than 18 years old undergoing a cardiac surgical procedure at Boston Children's Hospital with cardiopulmonary bypass.
Description
Inclusion Criteria:
- less than 18 years old
- undergoing cardiac surgery with cardiopulmonary bypass at Boston Children's Hospital
Exclusion Criteria:
- undergoing an emergent procedure and do not have more than 1 hour ahead of time to review the consent
- patient in a moribund condition American Society of Anesthesiology (ASA 5)
- patient with a hematological and/or oncological disease
- Jehovah witnesses
- patient on preoperative mechanical ventilation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Cardiac Surgery Patients
Patients less than 18 years old who undergo cardiac surgical procedures on cardiopulmonary bypass.
|
Discarded blood samples will be collected from routine clinical labs collected before and after surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Characterization of postoperative neurological impairment
Time Frame: 24 hours following surgery
|
Understand the correlation between measured proinflammatory cytokines and several proteins that are highly expressed in brain cells with postoperative neurological status.
|
24 hours following surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 1, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Study Registration Dates
First Submitted
March 20, 2025
First Submitted That Met QC Criteria
March 26, 2025
First Posted (Actual)
March 28, 2025
Study Record Updates
Last Update Posted (Actual)
March 17, 2026
Last Update Submitted That Met QC Criteria
March 16, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Cardiovascular Diseases
- Wounds and Injuries
- Heart Diseases
- Congenital Abnormalities
- Cardiovascular Abnormalities
- Craniocerebral Trauma
- Trauma, Nervous System
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities
- Heart Defects, Congenital
- Brain Injuries
Other Study ID Numbers
- IRB-P00050907
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.